Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry.


Journal

European journal of preventive cardiology
ISSN: 2047-4881
Titre abrégé: Eur J Prev Cardiol
Pays: England
ID NLM: 101564430

Informations de publication

Date de publication:
05 2019
Historique:
pubmed: 12 2 2019
medline: 1 9 2020
entrez: 12 2 2019
Statut: ppublish

Résumé

The aim of this study was to determine whether the Joint European Societies guidelines on secondary cardiovascular prevention are followed in everyday practice. A cross-sectional ESC-EORP survey (EUROASPIRE V) at 131 centres in 81 regions in 27 countries. Patients (<80 years old) with verified coronary artery events or interventions were interviewed and examined ≥6 months later. A total of 8261 patients (females 26%) were interviewed. Nineteen per cent smoked and 55% of them were persistent smokers, 38% were obese (body mass index ≥30 kg/m A large majority of coronary patients have unhealthy lifestyles in terms of smoking, diet and sedentary behaviour, which adversely impacts major cardiovascular risk factors. A majority did not achieve their blood pressure, low-density lipoprotein cholesterol and glucose targets. Cardiovascular prevention requires modern preventive cardiology programmes delivered by interdisciplinary teams of healthcare professionals addressing all aspects of lifestyle and risk factor management, in order to reduce the risk of recurrent cardiovascular events.

Identifiants

pubmed: 30739508
doi: 10.1177/2047487318825350
doi:

Substances chimiques

Cardiovascular Agents 0
Hydroxymethylglutaryl-CoA Reductase Inhibitors 0

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

824-835

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Auteurs

Kornelia Kotseva (K)

1 European Society of Cardiology, Sophia Antipolis, France.
2 National Heart and Lung Institute, Imperial College London, UK.

Guy De Backer (G)

1 European Society of Cardiology, Sophia Antipolis, France.
3 Department of Public Health and Primary Care, Ghent University, Belgium.

Dirk De Bacquer (D)

1 European Society of Cardiology, Sophia Antipolis, France.
3 Department of Public Health and Primary Care, Ghent University, Belgium.

Lars Rydén (L)

1 European Society of Cardiology, Sophia Antipolis, France.
4 Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.

Arno Hoes (A)

1 European Society of Cardiology, Sophia Antipolis, France.
5 Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, The Netherlands.

Diederick Grobbee (D)

1 European Society of Cardiology, Sophia Antipolis, France.
6 Julius Global Health, Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, The Netherlands.

Aldo Maggioni (A)

1 European Society of Cardiology, Sophia Antipolis, France.
7 ANMCO Research Centre, Florence, Italy.

Pedro Marques-Vidal (P)

1 European Society of Cardiology, Sophia Antipolis, France.
8 Department of Medicine, Internal Medicine, Lausanne University Hospital, Switzerland.

Catriona Jennings (C)

1 European Society of Cardiology, Sophia Antipolis, France.
2 National Heart and Lung Institute, Imperial College London, UK.

Ana Abreu (A)

9 Hospital Santa Marta, Centro Hospitalar de Lisboa Central, Lisbon, Portugal.

Carlos Aguiar (C)

1 European Society of Cardiology, Sophia Antipolis, France.
10 Hospital Santa Cruz, Centro Hospitalar de Lisboa Ocidental, Lisbon, Portugal.

Jolita Badariene (J)

11 Clinic of Cardiac and Vascular diseases, Medical Faculty, Vilnius University, Lithuania.
12 Centre of Cardiology and Angiology, Vilnius University Hospital Santaros Klinikos, Lithuania.

Jan Bruthans (J)

1 European Society of Cardiology, Sophia Antipolis, France.
13 Centre for Cardiovascular Prevention, Charles University in Prague, First Faculty of Medicine and Thomayer Hospital, Czech Republic.

Almudena Castro Conde (A)

14 Cardiac Rehabilitation Unit, Cardiology Department, Hospital Universitario La Paz, Madrid, Spain.

Renata Cifkova (R)

1 European Society of Cardiology, Sophia Antipolis, France.
13 Centre for Cardiovascular Prevention, Charles University in Prague, First Faculty of Medicine and Thomayer Hospital, Czech Republic.

Jim Crowley (J)

1 European Society of Cardiology, Sophia Antipolis, France.
15 Department of Cardiology, Galway University Hospital and Croí, the West of Ireland Cardiac and Stroke Foundation, Croí Heart and Stroke Centre, Galway, Ireland.

Kairat Davletov (K)

16 School of Public Health, Public Health Research Centre, Kazakh National Medical University, Almaty, Kazakhstan.

Jaap Deckers (J)

1 European Society of Cardiology, Sophia Antipolis, France.
17 Erasmus MC, Rotterdam, The Netherlands.

Delphine De Smedt (D)

1 European Society of Cardiology, Sophia Antipolis, France.
3 Department of Public Health and Primary Care, Ghent University, Belgium.

Johan De Sutter (J)

1 European Society of Cardiology, Sophia Antipolis, France.
18 Department of Internal Medicine and Paediatrics, Ghent University, Belgium.
19 AZ Maria Middelares Ghent, Belgium.

Mirza Dilic (M)

1 European Society of Cardiology, Sophia Antipolis, France.
20 Medical Faculty, University of Sarajevo, Bosnia and Herzegovina.

Marina Dolzhenko (M)

21 Supyk National Medical Academy of Postgraduate Education, Kiev, Ukraine.

Vilnis Dzerve (V)

1 European Society of Cardiology, Sophia Antipolis, France.
22 Institute of Cardiology and Regenerative Medicine, University of Latvia, Riga, Latvia.

Andrejs Erglis (A)

1 European Society of Cardiology, Sophia Antipolis, France.
23 Pauls Stradins Clinical University Hospita, University of Latvia, Riga, Latvia.

Zlatko Fras (Z)

1 European Society of Cardiology, Sophia Antipolis, France.
24 Preventive Cardiology Unit, Department of Vascular Medicine, Division of Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia.
25 Medical Faculty, University of Ljubljana, Slovenia.

Dan Gaita (D)

1 European Society of Cardiology, Sophia Antipolis, France.
26 Universitatea de Medicina si Farmacie Victor Babes, Institutul de Boli Cardiovasculare, Clinica de Recuperare Cardiovasculara, Timisoara, Romania.

Nina Gotcheva (N)

27 National Heart Hospital, Dept Cardiology, Sofia, Bulgaria.

Peter Heuschmann (P)

28 Institute of Clinical Epidemiology and Biometry, University of Würzburg, Germany.
29 Clinical Trial Centre, University Hospital Würzburg, Germany.
30 Comprehensive Heart Failure Centre, University and University Hospital Würzburg, Germany.

Hosam Hasan-Ali (H)

31 Assiut University Heart Hospital, Cardiovascular Medicine Department, Egypt.

Piotr Jankowski (P)

32 Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland.

Nebojsa Lalic (N)

33 Department for Metabolic Disorder, Intensive Treatment and Cell Therapy in Diabetes, Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Centre of Serbia, Belgrade, Serbia.

Seppo Lehto (S)

1 European Society of Cardiology, Sophia Antipolis, France.
34 Varkaus Hospital, Finland.

Dragan Lovic (D)

1 European Society of Cardiology, Sophia Antipolis, France.
35 Clinic for Internal Disease Intermedic, Cardiology Department, Hypertension Centre, Nis, Serbia.

Silvia Mancas (S)

26 Universitatea de Medicina si Farmacie Victor Babes, Institutul de Boli Cardiovasculare, Clinica de Recuperare Cardiovasculara, Timisoara, Romania.

Linda Mellbin (L)

1 European Society of Cardiology, Sophia Antipolis, France.
4 Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.

Davor Milicic (D)

1 European Society of Cardiology, Sophia Antipolis, France.
36 University of Zagreb School of Medicine & University Hospital Centre Zagreb, Croatia.

Erkin Mirrakhimov (E)

1 European Society of Cardiology, Sophia Antipolis, France.
37 Kyrgyz State Medical Academy, Bishkek, Kyrgyzstan.
38 National Centre of Cardiology and Internal Medicine named after academician Mirrakhimov MM, Bishkek, Kyrgyzstan.

Rafael Oganov (R)

39 National Research Centre for Preventive Medicine, Directorate, Moscow, Russia.

Nana Pogosova (N)

40 Federal State Budget Organization, National Medical Research Centre of Cardiology of the Ministry of Healthcare of the Russian Federation, Moscow, Russia.

Zeljko Reiner (Z)

1 European Society of Cardiology, Sophia Antipolis, France.
41 University Hospital Centre Zagreb, School of Medicine, University of Zagreb, Croatia.

Stefan Stöerk (S)

30 Comprehensive Heart Failure Centre, University and University Hospital Würzburg, Germany.
42 Department of Medicine I, University Hospital Würzburg, Germany.

Lâle Tokgözoğlu (L)

1 European Society of Cardiology, Sophia Antipolis, France.
43 Department of Cardiology, Hacettepe University, Ankara, Turkey.

Costas Tsioufis (C)

1 European Society of Cardiology, Sophia Antipolis, France.
44 First Department of Cardiology, Medical School, National and Kapodistrian University of Athens, Greece.

Dusko Vulic (D)

45 Centre for Medical Research, School of Medicine, University of Banja Luka, Republic of Srpska, Bosnia and Herzegovina.

David Wood (D)

1 European Society of Cardiology, Sophia Antipolis, France.
2 National Heart and Lung Institute, Imperial College London, UK.
46 National University of Ireland, Galway, Ireland *Listed in Supplemental Appendix.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH